Short Communication on “MATS: Global Coverage Estimates for 4CMenB, a Novel Multicomponent Meningococcal B Vaccine”

Medini D and Vernikos G

Meningococcal antigen typing system (MATS) - the golden standard in many reference labs worldwide–for rapid, reproducible and accurate (conservative nonetheless) prediction of Bexsero strain coverage, can pave the way towards a data-driven decision making of national immunization technical advisory groups (NITAGs), allowing indirect comparison of immunization policies across countries and regions leading to rapid adaptation of public health policy decisions based on worldwide datasets. Нe recent milestone of the UK national infant routine recommendation and reimbursement, paves the way for other nations to follow, bringing closer the pediatric community to the vision of a meningitis free world.